Allievex is a clinical-stage biopharmaceutical company dedicated to developing therapies for rare pediatric neurodegenerative diseases. Their lead product candidate, tralesinidase alfa, is an enzyme replacement therapy aimed at treating Sanfilippo syndrome type B.